Twelve years ago, while coaching in the Southeastern Conference at the University of Kentucky, his life took an unexpected ...

Exelixis stock shines with 36% CABOMETYX sales growth, promising zanzalintinib market expansions, and raised 2025 guidance.

Companies like AstraZeneca, Daiichi Sankyo, Pfizer and Merck are learning from previous setbacks in the ADC space to improve ...

Cancer Detection and Positive Predictive Value Substantially Higher Than the Previously Published PATHFINDER Study MENLO PARK, Calif., June 18, 2025 /PRNewswire/ ...

MONDAY, June 23, 2025 (HealthDay News) — The National Institutes of Health (NIH) will fund studies of the long-term health ...

" PA is an independent, nonpartisan, and nonprofit newsroom producing investigative and public-service journalism that holds ...

ORION CORPORATION PRESS RELEASE 20 JUNE 2025 at 13.30 EEST CHMP recommends third indication for darolutamide for patients with advanced prostate cancer CHMP adopts positive opinion for the ...

Adolescents and young adults (AYAs) with cancer face numerous challenges, including financial toxicity due to the high cost ...

Timely investigation needed in the wake of a rising incidence While monitoring of bowel health lacks inherent prestige, the ...

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on ...

You may report side effects to the FDA at 1-800 ... including estrogen receptor-positive breast cancer, which is a form of hormone receptor-positive breast cancer, the most prevalent type of ...

HR-positive breast cancer, characterized by the expression ... We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view.